Slattery and colleagues showed that genetic variations in IFN-γ, specifically in IFNGR or IRFs, are associated with the increased risk of developing CRC and decreased survival after diagnosis (84, 85). This evidence concerns the gene IFNGR1 and colorectal carcinoma.